Marvel Cinematic Universe Another Day, Another Marvel Star Offering A Cryptic Tease About A Possible Avengers: Doomsday Return Marvel Cinematic Universe The Key Way Thunderbolts*’ Post-Credits Scene ...

Filed Under: Ant-Man 2: Ant-Man And The Wasp Pretty much every past MCU cast member has been, at some point, rumored to appear in the upcoming blockbusters, so it's not unreasonable to assume that ...

Eli Lilly delivered 54% revenue growth in Q3 2025, raised full-year guidance, and remains a defensive haven amid market volatility. LLY's obesity and diabetes franchise, led by Zepbound, Mounjaro, and ...

The 150-year-old drugmaker is the first company in health care to hit the milestone. By Rebecca Robbins Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, ...

Silicon Valley’s giants crowd the list of the world’s most valuable companies, but drugmaker Eli Lilly is hot on their heels. The company topped a market capitalization of $1 trillion on Friday, ...

Sen. Ruben Gallego (D-Ariz.) is asking for more information on Eli Lilly’s recently announced agreement with the Trump administration regarding the sale of its GLP-1 medication. In a letter to Lilly ...

Eli Lilly shares rose again Tuesday, their sixth increase in the past seven sessions. The drugmaker's market cap also closed at a record, $973.8 billion, as Lilly inched closer to the $1 trillion ...

Nov 13 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab and Eli Lilly (LLY.N), opens new tab denied weight-loss drug partnership with Mangoceuticals (MGRX.O), opens new tab on Thursday, hours after ...

Both Eli Lilly and Novo Nordisk are denying a telehealth company’s claim of having struck partnerships with the two companies to provide direct access to their popular obesity meds. Thursday morning, ...

Eli Lilly is inking a $100 million-plus biobucks deal with Insilico Medicine in hopes of using artificial intelligence to discover new drugs. The Indianapolis Big Pharma will combine Insilico’s Pharma ...

Eli Lilly (LLY) has reached a research and licensing agreement worth up to $1.2B with SanegeneBio to develop and commercialize RNAi therapeutics for metabolic diseases, the Boston, Massachusetts-based ...

ARANSAS PASS, Texas — Officials from across the Coastal Bend gathered for San Patricio's State of the County in Aransas Pass Wednesday afternoon. RELATED: How to File Hail Damage Claims After Coastal ...